Improvement in Palivizumab Administration in Severely Immunocompromised Children: A Single-institution Quality Improvement Initiative
{{output}}
Introduction: Palivizumab reduces severe respiratory syncytial virus (RSV) infection risk in immunocompromised children. However, guidance on palivizumab prophylaxis for immunocompromised children has remained vague. We developed... ...
